GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » H U Group Holdings Inc (OTCPK:MRCHF) » Definitions » Research & Development

H U Group Holdings (H U Group Holdings) Research & Development : $0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is H U Group Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. H U Group Holdings's Research & Development for the three months ended in Mar. 2024 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.


H U Group Holdings Research & Development Historical Data

The historical data trend for H U Group Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H U Group Holdings Research & Development Chart

H U Group Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

H U Group Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

H U Group Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H U Group Holdings  (OTCPK:MRCHF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


H U Group Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of H U Group Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


H U Group Holdings (H U Group Holdings) Business Description

Traded in Other Exchanges
Address
Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.

H U Group Holdings (H U Group Holdings) Headlines

No Headlines